Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.
Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A, Meehan M. Webb A, et al. Among authors: nicolson m. J Clin Oncol. 1997 Jan;15(1):261-7. doi: 10.1200/JCO.1997.15.1.261. J Clin Oncol. 1997. PMID: 8996151 Clinical Trial.
High-dose melphalan for multiple myeloma: long-term follow-up data.
Cunningham D, Paz-Ares L, Gore ME, Malpas J, Hickish T, Nicolson M, Meldrum M, Viner C, Milan S, Selby PJ, et al. Cunningham D, et al. Among authors: nicolson m. J Clin Oncol. 1994 Apr;12(4):764-8. doi: 10.1200/JCO.1994.12.4.764. J Clin Oncol. 1994. PMID: 8151320
A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas.
Rigg A, Cunningham D, Gore M, Hill M, O'Brien M, Nicolson M, Chang J, Watson M, Norman A, Hill A, Oates J, Moore H, Ross P. Rigg A, et al. Among authors: nicolson m. Br J Cancer. 1997;75(1):101-5. doi: 10.1038/bjc.1997.16. Br J Cancer. 1997. PMID: 9000605 Free PMC article. Clinical Trial.
Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A. Ross P, et al. Among authors: nicolson m. J Clin Oncol. 2002 Apr 15;20(8):1996-2004. doi: 10.1200/JCO.2002.08.105. J Clin Oncol. 2002. PMID: 11956258 Clinical Trial.
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.
Sumpter K, Harper-Wynne C, Cunningham D, Rao S, Tebbutt N, Norman AR, Ward C, Iveson T, Nicolson M, Hickish T, Hill M, Oates J. Sumpter K, et al. Among authors: nicolson m. Br J Cancer. 2005 Jun 6;92(11):1976-83. doi: 10.1038/sj.bjc.6602572. Br J Cancer. 2005. PMID: 15928658 Free PMC article. Clinical Trial.
The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma--individual patient data from 1775 patients in four randomised controlled trials.
Chau I, Norman AR, Cunningham D, Oates J, Hawkins R, Iveson T, Nicolson M, Harper P, Seymour M, Hickish T. Chau I, et al. Among authors: nicolson m. Ann Oncol. 2009 May;20(5):885-91. doi: 10.1093/annonc/mdn716. Epub 2009 Jan 22. Ann Oncol. 2009. PMID: 19164454 Free article.
259 results